Table: Fuso Pharmaceutical - Q1 parent results

Fuso Pharmaceutical Industries

09/08/2023 05:40

Aug 9 (Reuters)- 
             Fuso Pharmaceutical Industries Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2023        Jun 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             13.51               12.37            53.30    
                 (+9.2 pct)          (-1.8 pct)       (+4.5 pct)  
  Operating        589 mln             622 mln            2.00    
                 (-5.2 pct)          (+1.6 pct)       (-9.4 pct)  
  Recurring        658 mln             774 mln            2.00    
                 (-15.0 pct)         (-0.8 pct)       (-9.7 pct)  
  Net              479 mln             559 mln            1.30    
                 (-14.2 pct)         (+2.1 pct)       (-19.0 pct) 
  EPS             54.71 yen           63.76 yen       148.21 yen  
  Ann Div                             70.00 yen        70.00 yen  
  -Q2 div                             30.00 yen        35.00 yen  
  -Q4 div                             40.00 yen        35.00 yen  
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T